Core Viewpoint - The company has announced its 2024 annual profit distribution plan, which includes a cash dividend of 7.50 RMB per 10 shares, totaling 129,130,350 RMB to be distributed to shareholders [1][5]. Summary by Sections Profit Distribution Plan - The 2024 annual profit distribution plan was approved at the shareholders' meeting held on May 21, 2025, based on a total share capital of 172,173,800 shares [1][3]. - The cash dividend of 7.50 RMB per 10 shares (including tax) will be distributed, with a total cash dividend amounting to 129,130,350 RMB [1][5]. Implementation Details - The implementation of the profit distribution plan is consistent with the approved distribution plan and its adjustment principles [3]. - The time from the approval of the profit distribution plan to its implementation does not exceed two months [4]. Key Dates - The record date for the equity distribution is June 12, 2025, and the ex-dividend date is June 13, 2025 [6]. Distribution Recipients - The distribution will be made to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, as of the close of trading on June 12, 2025 [7]. Distribution Method - Cash dividends for A-share shareholders will be directly credited to their accounts on June 13, 2025 [9]. - The company will bear all legal responsibilities if there are insufficient dividends due to a reduction in shares during the distribution application period [9]. Adjustment of Parameters - The minimum selling price for major shareholders and executives will be adjusted based on the cash dividend distribution, with the new minimum price set at 18.68 RMB per share after this distribution [9].

Group 1 - The company has approved a profit distribution plan for the year 2024, which includes a cash dividend of 7.50 RMB per 10 shares, totaling 129,130,350 RMB to be distributed among shareholders [1][2] - The total share capital as of December 31 is 172,173,800 shares, and no stock dividends or capital reserve transfers will be made [1][2] - The dividend distribution will be subject to different tax rates based on the type of shareholder, with specific provisions for Hong Kong investors and domestic investors [1][2] Group 2 - The record date for the dividend distribution is set for June 12, 2025, and the ex-dividend date is June 13, 2025 [1][2] - The distribution will be directly credited to the shareholders' accounts through their securities companies or other custodians [1][2] - The company assumes all legal responsibilities for any discrepancies in the cash dividend distribution due to changes in shareholders' accounts during the application period [1][2] Group 3 - The minimum selling price for major shareholders and executives will be adjusted to 18.68 RMB per share following the dividend distribution [3] - The initial public offering price was set at 20.08 RMB per share, which will also be adjusted based on the dividend distribution [3]

证券代码：001328 证券简称：登康口腔 公告编号：2025-027 重庆登康口腔护理用品股份有限公司 2024年年度权益分派实施公告 4.本次利润分配实施距离股东会审议通过的时间未超过两个月。 二、本次权益分派实施方案 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 重庆登康口腔护理用品股份有限公司（以下简称"公司"）《2024年度利润分配 方案》已获2025年5月21日召开的2024年年度股东会审议通过，现将公司2024年年度权 益分派事宜公告如下： 一、股东会审议通过的利润分配方案基本情况 1.公司2024年年度股东会审议通过的《2024年度利润分配方案》为：按公司2024 年12月31日总股本172,173,800股为基数，向全体股东每10股派发现金红利7.50元（含 税），共计派发现金红利129,130,350.00元人民币，不送红股、不进行资本公积转增股 本。 2.自利润分配方案披露至权益分派实施期间，公司股本总额未发生变化。 3.本次实施的利润分配方案与公司2024年年度股东会审议通过的分配方案及其调 整原则一致。 本公司2024年年度权益分派 ...

Core Viewpoint - The cosmetics retail sales in China for January to April 2025 showed a year-on-year increase of 4%, underperforming the overall retail market by 0.7 percentage points, but this represents an improvement compared to 2024. The industry is characterized by four key trends: innovation in personal care products, breakthroughs in ingredient technology, rising emotional consumption, and the continuation of affordable consumption [1][3]. Investment Recommendations - The company recommends increasing holdings in the personal care sector, highlighting quality companies that benefit from product innovation and opportunities in Douyin channels, with key recommendations including Ruoyuchen (003010), Dengkang Oral (001328), and Runben Co. [2] - In the beauty sector, structural opportunities are identified, with key recommendations for companies like Jinbo Biological, Juzi Biological, and Marubi Co. that are positioned to benefit from the collagen restructuring trend. Additionally, brands like Maogeping, Shumei Co., Proya (603605), and Shanghai Jahwa (600315) are expected to gain from the overall increase in domestic market share [2]. - Companies expected to bottom out and potentially see a turning point include Lafang Household (603630), Shuiyang Co. (300740), Betaini (300957), Furuida (600223), Huaxi Biological, Fulejia (301371), Meilitiantian Medical Health, and Qingsong Co. (300132) [2]. Industry Overview - Demand remains stable, with the rise of domestic brands in the beauty and personal care sectors accelerating. The cosmetics retail sales for January to April 2025 increased by 4% year-on-year, which is a 0.7 percentage point underperformance compared to the overall retail market, but shows improvement from 2024. The overall demand is stable, with leading domestic brands performing well and the rise of new domestic brands spreading from beauty to personal care categories [3][4]. Trends - The industry is witnessing several trends: 1) Personal care transformation with new products in traditional categories, supported by content e-commerce creating a favorable environment for new product launches [4]. 2) Ingredient innovation, particularly in collagen restructuring, with various types and structural innovations expanding application scenarios [4]. 3) Emotional consumption, where cultural, stylistic, and experiential demands are driving the growth of domestic trends in cosmetics and fragrances [4]. 4) Affordable consumption, where the trend for cost-effectiveness continues under supply-demand resonance, benefiting strong supply chains and well-operated brands [4]. Key Companies - Looking ahead to 2025, the market risk appetite is expected to recover significantly. The beauty sector is characterized by substantial changes and a clear trend of rising domestic brands, indicating strong growth potential and leadership in new consumption [5]. The differentiation among brands is increasing, emphasizing the selection of high-growth targets driven by product innovation and attention to marginal improvements [5].

Investment Rating - The report maintains a positive outlook on the pet supplies sector, AI glasses, and the home improvement market, highlighting potential acquisition opportunities and new product launches [2][6][27]. Core Insights - The report emphasizes the resilience of essential consumer goods in the personal care sector, with a notable trend towards domestic brands, particularly during promotional events like the 618 sales [6][14]. - The pet supplies market is experiencing consolidation opportunities, with companies like Tianyuan Pet and Yiyi Co. being recommended for their strong market positions and growth potential [6][7]. - The AI glasses segment is expected to see significant product launches in the latter half of 2025, driven by collaborations between major tech companies [12][20]. - The report highlights the positive impact of government policies on the real estate market, which is anticipated to stabilize and boost related sectors, including home improvement [27][28]. Summary by Sections New Consumer Trends - The report identifies the pet supplies sector as a key area for mergers and acquisitions, recommending companies such as Tianyuan Pet and Yiyi Co. for their strong market presence and growth prospects [6][7]. - AI glasses are positioned for growth with new product launches expected from major players like Google and XREAL, indicating a robust market expansion [12][20]. Personal Care Sector - The personal care market shows resilience, with domestic brands gaining traction, particularly during promotional periods [14]. - Recommended companies in this sector include Baiya Co., Haoyue Care, and Dengkang Oral Care, which are expected to benefit from the ongoing consumer trends [14][15]. Home Improvement and Real Estate - The report notes that government initiatives are likely to support the real estate market, leading to improved conditions for the home improvement sector [27][28]. - Companies like Sophia and Oppein Home are highlighted for their potential to benefit from the anticipated recovery in the housing market [23][27]. Paper Industry - The report mentions a price increase in the paper sector, with expectations for price stabilization due to supply adjustments [25]. - Recommended companies in this space include Sun Paper, which is noted for its integrated operations and cost advantages [25]. Export and Trade - The report discusses the impact of tariff changes on exports, particularly in the light industrial sector, with a focus on companies that have a strong competitive edge [6][20].

沪指5月22日下跌0.22%，申万所属行业中，今日上涨的有3个，涨幅居前的行业为银行、传媒、家用电 器，涨幅分别为1.00%、0.12%、0.04%。跌幅居前的行业为美容护理、社会服务，跌幅分别为2.03%、 1.80%。美容护理行业位居今日跌幅榜首位。 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 002094 | 青岛金王 | 6.60 | 38.89 | 49250.10 | | 600249 | 两面针 | 4.83 | 22.21 | 16705.65 | | 001328 | 登康口腔 | 2.73 | 14.01 | 2803.29 | | 688363 | 华熙生物 | -1.01 | 1.08 | 1449.76 | | 002511 | 中顺洁柔 | -0.14 | 1.34 | 1289.38 | | 300886 | 华业香料 | -5.41 | 21.25 | 262.17 | | 300955 | 嘉亨家化 | 3.58 | 24.50 | 122.21 | | 30 ...

Meeting Overview - The annual general meeting of Chongqing Dengkang Oral Care Products Co., Ltd. was held on May 21, 2025, at 14:30 [2] - The meeting utilized a combination of on-site and online voting methods for decision-making [4] Attendance - A total of 87 shareholders and their representatives attended the meeting, representing 121,752,710 shares, which accounts for 70.7150% of the company's voting shares [7] - Out of these, 5 shareholders attended the meeting in person, representing 118,673,500 shares (68.9266% of voting shares) [8] - 82 shareholders participated via online voting, representing 3,079,210 shares (1.7884% of voting shares) [9] Resolutions Passed - The following resolutions were approved during the meeting: - The 2024 Annual Report and its summary received 121,748,110 votes in favor (99.9962%) [11] - The 2024 Annual Board Work Report was also approved with the same voting results [12] - The 2024 Annual Supervisory Board Work Report was passed with identical support [13] - The profit distribution plan for 2024 was approved with 121,748,110 votes in favor (99.9962%) [15] - The reappointment of the accounting firm was approved with 121,725,810 votes in favor (99.9779%) [16] - The remuneration plan for directors, supervisors, and senior management for 2025 was approved with 109,074,110 votes in favor (99.9952%) [17] - The proposal to use part of the idle raised funds and self-owned funds for cash management was approved with 120,385,466 votes in favor (98.8770%) [18] - The proposal to use part of the excess raised funds to permanently supplement working capital was approved with 121,748,110 votes in favor (99.9962%) [19] Legal Opinion - The legal opinion provided by Shanghai Jintiancheng (Guangzhou) Law Firm confirmed that the meeting's procedures, qualifications of the conveners and attendees, voting procedures, and results were in compliance with relevant laws and regulations [21]

证券代码：001328 证券简称：登康口腔 公告编号：2025-026 重庆登康口腔护理用品股份有限公司 2024年年度股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东会无否决议案或修改议案的情况； 2.本次股东会上没有新提议案提交表决； 3.本次股东会不涉及变更前次股东会决议的情况； 4.本次股东会采取现场方式召开，采用现场投票和网络投票相结合的方式进行表 决。 一、会议召开情况 （一）会议召开时间 1.现场会议召开时间：2025年5月21日（星期三）14:30。 2.网络投票时间： （1）深圳证券交易所交易系统进行网络投票的具体时间为2025年5月21日 9:15— 9:25，9:30—11:30和13:00—15:00； （2）深圳证券交易所互联网投票系统投票的具体时间为2025年5月21日9:15- 15:00。 （二）会议召开和表决方式 （三）召集人 重庆登康口腔护理用品股份有限公司（以下简称"公司"）董事会。 （四）现场会议召开地点 公司办公楼一楼报告厅（重庆市江北区海尔路389号）。 - 1 - （五）会议 ...

上海锦天城（广州）律师事务所 关于重庆登康口腔护理用品股份有限公司 2024 年年度股东会的 法律意见书 地址：广州市天河区珠江西路 5 号广州国际金融中心第 60 层 电话：020-8928 1168 传真：020-8928 5188 邮编：510623 上海锦天城（广州）律师事务所 法律意见书 上海锦天城（广州）律师事务所 关于重庆登康口腔护理用品股份有限公司 2024 年年度股东会的 法律意见书 致：重庆登康口腔护理用品股份有限公司 上海锦天城（广州）律师事务所（以下简称"本所"）接受重庆登康口腔 护理用品股份有限公司（以下简称"公司"）委托，就公司召开 2024 年年度股 东会（以下简称"本次股东会"或"本次会议"）的有关事宜，根据《中华人 民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）和《上市公司股东会规则（2025 年修订）》（以 下简称"《股东会规则》"）、《深圳证券交易所上市公司股东会网络投票实 施细则（2025 年修订）》等法律、法规、规章和其他规范性文件以及《重庆登 康口腔护理用品股份有限公司章程》（以下简称"《公司章程》"）的有关规 定， ...

子公司股权预挂牌仅半个月后竟终止，广东锦龙发展股份有限公司（以下简称"锦龙股份"）的"突然决策"引 发市场关注。5月19日，锦龙股份公告称，为防止公司在出售中山证券股权后可能出现主要资产为现金或者无 具体经营业务的情形，拟终止本次重组。值得一提的是，5月6日，上述股权才预挂牌。在终止筹划相关事项 的同时，锦龙股份也拟借款展期。年报数据显示，截至2024年末，锦龙股份的资产负债率高达81.09%，且归 母净利润也已连续四年亏损。有分析人士直言，上述原因更像是一种借口。"可能是出售过程中出现了问题， 或公司改变主意不想卖了。" 预挂牌半月后终止 5月19日，锦龙股份发布公告表示，为加快推进公司业务转型，并为公司向实体经济转型和拓展新质生产力创 造有利条件，此前公司拟转让所持有的中山证券全部67.78%股权，现公司决定终止本次重组。 对于终止筹划的原因，锦龙股份表示，此前已有意向受让方与公司进行接洽，且已有意向受让方对中山证券 开展了尽职调查。根据公司实际情况和《重组管理办法》相关规定，为防止公司在出售中山证券股权后可能 出现主要资产为现金或者无具体经营业务的情形，决定终止本次重组。 在上述消息公布后的首个交易日， ...